Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report.

Saved in:
Bibliographic Details
Title: Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report.
Authors: Duarte FA; Department of Clinical Oncology, Oncoclinicas Group, Oncocentro, Rua Roma 561, 4th floor, Santa Lúcia, Belo Horizonte, MG, 30360-680, Brazil., Rodrigues LB; Department of Thoracic Surgery, Madre Teresa Hospital, Av. Raja Gabáglia, 1002, Gutierrez, Belo Horizonte, MG, 30380-090, Brazil., Paes FR; Department of Clinical Oncology, Oncoclinicas Group, Oncocentro, Rua Roma 561, 4th floor, Santa Lúcia, Belo Horizonte, MG, 30360-680, Brazil., Diniz PHC; Department of Clinical Oncology, Oncoclinicas Group, Oncocentro, Rua Roma 561, 4th floor, Santa Lúcia, Belo Horizonte, MG, 30360-680, Brazil. phdiniz@gmail.com., Lima HFCA; Department of Clinical Oncology, Oncoclinicas Group, Oncocentro, Rua Roma 561, 4th floor, Santa Lúcia, Belo Horizonte, MG, 30360-680, Brazil.
Source: BMC pulmonary medicine [BMC Pulm Med] 2021 Jan 28; Vol. 21 (1), pp. 43. Date of Electronic Publication: 2021 Jan 28.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2466
DOI:10.1186/s12890-020-01390-6